New drugs are being tested to determine whether they can protect brain cells from TBI (traumatic brain injury)
September 18, 2014, Kitchener, Ontario
Posted by: Robert Deutschmann, Personal Injury Lawyer
The American Military has been funding new research aimed at the prevention and treatment of TBI at a feverish pace over the last decade. An estimated 10-20 percent of the soldiers deployed to Afghanistan and Iraq suffered TBI.
This is good news for others who have sustained TBI as the discoveries are moving to civilian treatment as well. The American Military has been funding new research aimed at the prevention and treatment of TBI at a feverish pace over the last decade. An estimated 10-20 percent of the soldiers deployed to Afghanistan and Iraq suffered TBI.
This new line of research for neuroprotective treatment is a promising one for TBI as well as potentially other neurodegenerative diseases like ALS. When a TBI is sustained axon damage occurs in the brain. It is the axons that make the connections within the brain. It is hoped that the new series of drugs called P7C3 will block axon damage and preserve normal brain function after a TBI.
The study team of Dr. Ready and Dr. McKnight at UT Southwestern Medical Center have developed an orally administer neuroprotective drug for mice. Most promisingly it seems to produce a protective effect even when given 24-36 hours after the blast injury.
According to Dr. Peiper a co-researcher,
"Our ultimate goal is to facilitate development of a new class of neuroprotective drugs with wide applicability to treating patients with TBI and other currently untreatable forms of neurodegeneration".
|Posted under Brain Injury, Personal Injury, Spinal Cord Injury, Treatment
View All Posts
About Deutschmann Law
Deutschmann Law serves South-Western Ontario with offices in Kitchener-Waterloo, Cambridge, Woodstock, Brantford, Stratford and Ayr. The law practice of Robert Deutschmann focuses almost exclusively in personal injury and disability insurance matters. For more information, please visit www.deutschmannlaw.com or call us toll-free at 1-866-414-4878.
The opinions expressed here, while intended to provide useful information, should not be interpreted as legal recommendations or advice.